MedAxiom, the cardiovascular community’s premier source for organizational performance solutions, is excited to announce a new partnership with Zywie, a remote cardiac monitoring company specializing in wearable biosensor devices and cloud-based data analytic solutions.
“We are proud to welcome Zywie to the MedAxiom community,” said Joe Sasson, PhD, MedAxiom’s chief commercial officer and executive vice president of Ventures. “Remote rhythm monitoring is a crucial tool for diagnosing cardiac arrhythmias. Zywie’s unique and adaptable solutions offer an exciting opportunity to bring more innovations to our members, provide education on the options and strategies available to them, and advance our goal of transforming cardiovascular care together.”
Zywie offers multiple types of monitors to fit the needs of every physician and patient, including the ZywieNano™ patch, a compact adhesive patch that continuously monitors the heart’s electrical activity for up to 30 consecutive days. Zywie’s unique ability to analyze patients’ electrocardiograms in real time allows clinicians to proactively address abnormal heart rhythms before they worsen or become lethal.
“We are excited to announce our partnership with MedAxiom, the leader in cardiovascular organizational performance solutions,” said Andrew Carlton, vice president of Sales at Zywie. “Zywie reaffirms its dedication to advancing patient care through innovative cardiac diagnostics, and this partnership enables us to collaborate closely on that mission with MedAxiom’s extensive network and expertise. Together with MedAxiom, we are committed to delivering enhanced value to patients, healthcare providers and the broader cardiovascular community.”
Zywie’s platform has been shown to increase diagnostic yields and actionable data for providers over standard 14-day monitors by capturing the rhythms previously missed between days 15 to 30. For more information on Zywie and their solutions, visit their website and connect with them at our upcoming CV Transforum Fall’24 in Denver, Oct. 17 – 19.
